Treatment Indications: correction of deep facial wrinkles and folds (including severe nasolabial folds, forehead rhytides),, ), significant volume restoration in high‑load areas (cheeks, chin, nose),, ontouring with a high‑viscosity, highly stable gel demonstrating resistance to mechanical stress and minimal migration risk.
Release form: 1 × 1.1 mL pre‑filled syringe
Compound: 3D cross‑linked hyaluronic acid (non‑animal origin, produced via biofermentation) with particle size ~1000–1400 µm; lidocaine hydrochloride; phosphate‑buffered saline solution (pH 7).
Concentration of GC: 20 mg/mL
Lidocaine: 0.3 %
Indications: volumizing and structural contouring in the subcutaneous tissue layer:, restoration of lost volume in the mid‑face,, enhancement of chin and nose contours, correction of deep depressions and severe age‑related volume deficit;, applications requiring a high storage modulus (G’) and prolonged effect (12–18 months).